Transdermal Diagnostics is a technology platform to improve the prevention, diagnosis, and management of chronic conditions with diabetes.
Transdermal Diagnostics has raised $921K in total funding. The most recent round was Seed. The last funding was announced in September 2022.
Transdermal Diagnostics's investors include Empirical Ventures, Innovate UK, Pioneer Group, Bristol Private Equity Club, QUBIS Innovation Fund.
Transdermal Diagnostics is headquartered in Bath, United Kingdom.
Transdermal Diagnostics is a technology platform to improve the prevention, diagnosis, and management of chronic conditions with diabetes.
Transdermal Diagnostics is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Transdermal Diagnostics — Funding & Investors." VCBacked, September 6, 2022, https://www.vcbacked.co/company/transdermal-diagnostics. Accessed September 30, 2026.
VCBacked. (2022). Transdermal Diagnostics — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/transdermal-diagnostics
{{cite web |title=Transdermal Diagnostics — Funding & Investors |url=https://www.vcbacked.co/company/transdermal-diagnostics |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated